<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Immunoglobulins: anti-D (Rh0); Anti-D (Rh0) immunoglobulin; Rhesus incompatibility; Haemolytic disease of newborn, prevention" /><meta name="IX" content="Immunoglobulins: anti-D (Rh0); Anti-D (Rh0) immunoglobulin; Rhesus incompatibility; Haemolytic disease of newborn, prevention" /><title>14.5.3 Anti-D (Rh0) immunoglobulin: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP8478-anti-d-rh-0-immunoglobulin.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP8478-anti-d-rh-0-immunoglobulin.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP8478-anti-d-rh-0-immunoglobulin.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP8209-immunological-products-and-vaccines.htm">14 Immunological products and vaccines</a> &gt; <a href="PHP8429-immunoglobulins.htm">14.5 Immunoglobulins</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP8476-varicellazoster-immunoglobulin.htm" title="Previous: VARICELLA–ZOSTER IMMUNOGLOBULIN">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP8480-anti-d-rh-0-immunoglobulin.htm" title="Next: ANTI-D (Rh0) IMMUNOGLOBULIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>Stockley's Interaction Alerts (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/1234-k.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Anti-d immunoglobulins</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: A &gt; Interactions of Anti-d immunoglobulins</p></div></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/3893-f.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Immunoglobulins</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Immunoglobulins</p></div></li></ul><ul><li><h3>British National Formulary (39)</h3></li><li><a href="PHP5620-antithymocyte-immunoglobulin-rabbit.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT)</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 8 Malignant disease and immunosuppression &gt; 8.2 Drugs affecting the immune response &gt; 8.2.2 Corticosteroids and other immunosuppressants</p></div></li><li><a href="PHP5877-drugs-used-in-hypoplastic-haemolytic-and-renal-anaemias.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders</p></div></li><li><a href="PHP5925-idiopathic-thrombocytopenic-purpura.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Idiopathic thrombocytopenic purpura</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders &gt; 9.1.4 Drugs used in platelet disorders</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22immunoglobulins%22%22anti-d+(rh%22%22rhesus+incompatibility%22%22haemolytic+disease+of+newborn,+prevention%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (39)</a></li></ul><ul><li><h3>BNF for Children (34)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13913-drugs-used-in-hypoplastic-haemolytic-and-renal-anaemias.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP13946-drugs-used-in-platelet-disorders.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">9.1.4 Drugs used in platelet disorders</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 9 Nutrition and blood &gt; 9.1 Anaemias and some other blood disorders</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP14402-drugs-that-enhance-neuromuscular-transmission.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">10.2.1 Drugs that enhance neuromuscular transmission</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.2 Drugs used in neuromuscular disorders</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22immunoglobulins%22%22anti-d+(rh%22%22rhesus+incompatibility%22%22haemolytic+disease+of+newborn,+prevention%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (34)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (25)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/11739-l.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">AIDS Immunoglobulins</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Archive of Deleted Monographs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/3894-d.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Diphtheria Immunoglobulins</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Archive of Deleted Monographs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/14704-h.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Haemophilus Influenzae Immunoglobulins</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Archive of Deleted Monographs &gt; Drug Monographs</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22immunoglobulins%22%22anti-d+(rh%22%22rhesus+incompatibility%22%22haemolytic+disease+of+newborn,+prevention%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (25)</a></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c15-sec1-003.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Techniques of analysis</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 3: Pharmaceutical Analysis And Quality Control &gt; 15 Clinical Analysis</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c56-sec1-001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Introduction</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 6: Pharmacokinetics and Pharmacodynamics &gt; 56 Principles of Immunology</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E14E3E0R0D2677.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Antilymphocyte immunoglobulins</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E20E3E0R0D3206.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Immunoglobulins</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E4E3E0R0D552.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Normal immunoglobulins</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; N</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1><span>14.5.3 </span>Anti-D (Rh<sub>0</sub>) immunoglobulin</h1><?highlighter on?><div id="pC" class="jN"><p>Anti-D (Rh<sub>0</sub>) immunoglobulin is prepared from plasma taken from rhesus-negative donors who have been immunised against the anti-D-antigen. Anti-D (Rh<sub>0</sub>) immunoglobulin is used to prevent a rhesus-negative mother from forming antibodies to fetal rhesus-positive cells which may pass into the maternal circulation. The objective is to protect any subsequent child from the hazard of haemolytic disease of the newborn.</p> <p>Anti-D immunoglobulin should be administered to the mother following any sensitising episode (e.g. abortion, miscarriage and birth); it should be injected within 72 hours of the episode but even if a longer period has elapsed it may still give protection and should be administered. Anti-D (Rh<sub>0</sub>) immunoglobulin is also given when significant feto-maternal haemorrhage occurs in rhesus-negative women during delivery. The dose of anti-D immunoglobulin is determined according to the level of exposure to rhesus-positive blood.</p> <p>For routine antenatal prophylaxis NICE recommends that two doses of either 500 units <em>or</em> 1000–1650 units of anti-D immunoglobulin should be given, the first at 28 weeks' gestation and the second at 34 weeks; alternatively a single dose of 1500 units given between 28 and 30 weeks gestation can be used (see also NICE guidance below).</p> <p>Use of routine <em>antenatal</em> anti-D prophylaxis should be given irrespective of previous anti-D prophylaxis for a sensitising event early in the same pregnancy. Similarly, <em>postpartum</em> anti-D prophylaxis should be given irrespective of previous routine antenatal anti-D prophylaxis or antenatal anti-D prophylaxis for a sensitising event in the same pregnancy.</p> <div class="cI"><p class="cAE">NICE guidance</p><h3 class="cT">Routine antenatal anti-D prophylaxis for rhesus-negative women (August 2008)</h3><p>Routine antenatal anti-D prophylaxis should be offered to all non-sensitised pregnant women who are rhesus negative. </p></div> <div class="cI" id="PHP8479"><h3 class="cT">Note</h3><p>MMR vaccine may be given in the postpartum period with anti-D (Rh<sub>0</sub>) immunoglobulin injection provided that separate syringes are used and the products are administered into different limbs. If blood is transfused, the antibody response to the vaccine may be inhibited—measure rubella antibodies after 6–8 weeks and revaccinate if necessary.</p></div> <p>Anti-D (Rh<sub>0</sub>) immunoglobulin is also given to women of child-bearing potential after the inadvertent transfusion of rhesus-incompatible blood components and is used for the treatment of idiopathic thrombocytopenia purpura.</p> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP8480-anti-d-rh-0-immunoglobulin"><a href="PHP8480-anti-d-rh-0-immunoglobulin.htm" title="ANTI-D (Rh0) IMMUNOGLOBULIN">ANTI-D (Rh<sub>0</sub>) IMMUNOGLOBULIN</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP8476-varicellazoster-immunoglobulin.htm">Previous: VARICELLA–ZOSTER IMMUNOGLOBULIN</a> | <a class="top" href="PHP8478-anti-d-rh-0-immunoglobulin.htm#">Top</a> | <a accesskey="]" href="PHP8480-anti-d-rh-0-immunoglobulin.htm">Next: ANTI-D (Rh<sub>0</sub>) IMMUNOGLOBULIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>